Archive for the ‘Products’ Category

Take the Dysport Challenge in Seattle March 1 – April 30

Monday, March 1st, 2010

From March 1 until April 30, 2010, you can save $150 on 2 treatments with Dysport, the latest injectable wrinkle treatment containing botulinum toxin type a.

To take the “Dysport Challenge” you need to register at Dysportusa.com. According to the website, you can download a coupon rebate form within 14 days after your first Dysport treatment to receive a 75 dollar rebate check. If you love Dysport, you can repeat the process and get another rebate after 3 months.

Read more about Dysport with Dr. Heffernan in Seattle

Do I really need to wear sunscreen in the winter?

Tuesday, November 10th, 2009

Even in the winter, or on a cloudy, rainy Seattle day, you can be exposed to UVA/UVB rays.

You should get in the habit of protecting your skin with sunscreen on a daily basis. Choosing the right sunscreen for your face – one that addresses your skin type and skin conditions – is not always easy, but  the right sunscreen can prevent sun damage, skin problems, and skin cancer.  Harmful UV rays can damage skin cells deep within the skin’s surface, making your cells vulnerable to toxins (free-radicals) in the environment.

Our Favorite Sunscreen

My favorite sunscreen is IS Clinical SPF 25 treatment sunscreen. Because most IS Clinical sunscreensunscreens can be tacky when applied, many of my clients have been resistant to applying them every day. IS Clinical Treatment Sunscreen goes on so smooth you don’t even know it is there, even under your foundation.

IS Clinical treatment sunscreen will provide you with UVA/UVB broad-spectrum protection, reduce the appearance of erythema (redness), provide an antioxidant-rich protective seal, and may even soothe inflammation.

IS Clinical treatment sunscreen comes in clear and tinted formulas for darker skin (or if you just want a little extra color). The cost for one 8 oz. tube ranges from $33-36 and will last for several months.

Road to Sexy Lashes: Paved With Bimatoprost?

Tuesday, June 9th, 2009

Drugs sometimes make their way to the market inadvertently, and some even become ultra popular for uses that were never intended; such is the case with Allergan’s new offering, Latisse. The hot new eyelash enhancer was born out of a group of medications called topical prostaglandins, drugs frequently used to decrease intra-ocular pressure in glaucoma patients.

Doctors identified a particular ‘complication’ or side effect of using prostaglandins called “hypertrichosis,” a condition characterized by darkening, thickening, and lengthening of the eyelashes.

Allergan offered the topical prostaglandin Lumigan in 2001, a drug that contained the active ingredient bimatoprost. Two important precursors to Latisse occurred after the FDA gave clearance for Lumigan.

Jan Marini Skin Research Inc had over $2 million worth of product seized by the Food and Drug Administration.  The product, Age Intervention Eyelash, evidently contained bimatoprost, which was unapproved for cosmetic use at the time. Allergan later filed a patent infringement suit against Jan Marini and several other companies that had tried to market bimatoprost in their eyelash enhancing drugs.

Some doctors started prescribing Lumigan off-label to enhance eyelashes.  Knowing the desirable side effects it could produce. But Lumigan wasn’t formulated for cosmetic use and many believed more research was needed to confirm the safety of topical prostaglandins for cosmetic use.  

Clinical trials and further research is exactly what Alllergan Inc did.  In one early study, 278 healthy adults with minimal to moderate eyelash prominence applied bimatoprost or a placebo to their lash line.  The results were favorable; researchers observed “statistically significant differences in eyelash growth and resulting patient satisfaction” while only 3.6 percent experienced itchy eyes and redness, and only 2.9 percent experienced skin hyperpigmentation.  

Latisse received FDA approval late last year for the treatment of ‘inadequate’ eyelashes.  Allergan now owns the patent on all use of bimatoprost for eyelash enhancement.

For more information on Latisse in Seattle, Washington, contact us.

NIA24 Prevents and Reverses Premature Aging

Thursday, May 21st, 2009

The three major concerns women usually  share about their skin include, wrinkles, skin laxity, and age spots.

Such conditions may be indicators of premature aging due to sun damage, and if you don’t address them quickly, they can lead to undesirable skin conditions later in life – issues like uneven skin tone and severe wrinkles.

Fortunately, we now have decades of research available on cell rejuvenation, skin health, and the ways in which certain ingredients aid this process. It is a proven fact that products containing the three key antioxidant vitamins – A (Retin, Retinyl, Retinoic Acid or Retinol); C (Ascorbic Acid); and E (Tocopherol), as well as the nutrient Niacin, accelerate cell turnover.

Vitamin A is beneficial in multiple ways; the most important benefit is probably the stimulation of collagen growth. Vitamin C and E are super-charged rejuvenators, and the nutrient Niacin acts as a sort of damage control. Together these components naturally rejuvenate by ‘turning on’ the cells that make collagen and elastin. When combined in a product, they can effectively treat signs of premature aging.

The TODAY SHOW recently featured the NIA24™ product line, which contains several of these potent ingredients.

One of the most important factors in skin health is retaining moisture and replenishing the water in our skin. NIA24™ deeply hydrates skin while also protecting against the environment. It also reverses pre-existing skin damage by aiding body’s natural repair mechanisms. The ‘power ingredient’ in NIA24™ is NIACIN.

Niacin prevents melanin production from reaching the skin to reduce unwanted pigmentation. Once you start using NIA24™ new sun spots will stop appearing the next important step in the process will being - gentle exfoliation. You will shed off those brown spots and sun damaged areas revealing healthy, clear skin underneath.

For more info on skin care with NIA24, contact our Seattle surgery office.

Latisse Featured in People Magazine

Friday, May 1st, 2009

latisse_magThe recently published April ‘09 issue of People featured “312 easy style updates”  and one just happened to be Allergan’s new eyelash enhancement drug, Latisse.

Latisse is FDA approved for the treatment of hypotrichosis, i.e. inadequate eyelashes.  It is available by prescription only.  If you are interested or would like more information, contact our Seattle surgery office.

people_mag